AptarGroup

Aptar Declares Quarterly Dividend

Retrieved on: 
Thursday, October 14, 2021
Other Consumer, Packaging, Chemicals, Plastics, Manufacturing, Food, Beverage, Pharmaceutical, Consumer, Health, Cosmetics, Retail, AptarGroup, Food, Securities Exchange Act of 1934, Security (finance), Beauty, Engineering, Securities Act of 1933, Financial condition report, Result, NYSE, Analysis, Drug Quality and Security Act, Health, Patient, Form, Science, ATR, Interest, U.S. Securities and Exchange Commission, Forward-looking statement, Investor, Central Time

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share.
  • As previously announced, Aptar will hold a conference call on Friday, October 29, 2021 at 8:00 a.m. Central Time to discuss the Companys third quarter results for 2021.
  • Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

LianBio Appoints Jesse Wu to Board of Directors

Retrieved on: 
Wednesday, October 13, 2021
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, PepsiCo, MBA, Procter & Gamble, Inflammation, Growth, Business, AptarGroup, Economics, Procter, Johnson & Johnson, Patient, Economic development, Magnolia Award, Board, Duke, National Chengchi University, Ophthalmology, Pharmaceutical industry, Management, Fine chemical

LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, today announced the appointment of Jesse Wu to the companys Board of Directors.

Key Points: 
  • LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, today announced the appointment of Jesse Wu to the companys Board of Directors.
  • We are proud to welcome Jesse to the LianBio team, said Yizhe Wang, Ph.D., Chief Executive Officer of LianBio.
  • Mr. Wu also serves as a member of the Board of Visitors at Duke Universitys Fuqua School of Business.
  • Im excited to be joining LianBio at this time of growth for the company, said Mr. Wu.

Aptar to Host Virtual Capital Markets Day

Retrieved on: 
Thursday, September 9, 2021
Packaging, Medical Devices, Health, Manufacturing, Other Manufacturing, Pharmaceutical

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, will host a virtual Capital Markets Day on Friday, September 10, 2021.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, will host a virtual Capital Markets Day on Friday, September 10, 2021.
  • Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions.
  • Aptars innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

Sphera Announces Expanded Availability of Environmental, Social and Governance Reporting Solutions

Retrieved on: 
Thursday, September 9, 2021

CHICAGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sphera, a global leader in Environmental, Social and Governance (ESG) risk and performance management software, data and consulting services, announces the widespread availability of its integrated ESG solutions.

Key Points: 
  • CHICAGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sphera, a global leader in Environmental, Social and Governance (ESG) risk and performance management software, data and consulting services, announces the widespread availability of its integrated ESG solutions.
  • Connected, scalable software solutions to ensure transparency and increasethe efficiency of each stage of a customers sustainability and ESG journey.
  • Sphera has long been at the forefront of innovative sustainability reporting solutions, leveraging its triple-powered approach of Innovation, Information and Insights to help companies improve their ESG performance .
  • Verdantix, an independent analyst firm, recently named Sphera as a market leader for environmental compliance, sustainability management and sustainability reporting in its EHS Software Benchmark report.

Shirley Ryan AbilityLab Mourns the Passing of Joanne C. Smith, MD, President & CEO

Retrieved on: 
Tuesday, September 7, 2021

CHICAGO, Sept. 7, 2021 /PRNewswire/ -- Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago) today announced the untimely passing of Joanne C. Smith, MD, president and CEO.

Key Points: 
  • CHICAGO, Sept. 7, 2021 /PRNewswire/ -- Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago) today announced the untimely passing of Joanne C. Smith, MD, president and CEO.
  • Dr. Smith died following treatment for cancer, which she battled privately while continuing to fully lead Shirley Ryan AbilityLab.
  • "We are deeply saddened by the loss of our friend and leader, Dr. Joanne Smith," said M. Jude Reyes, board chair.
  • In 2006, a few years after earning her MBA from the University of Chicago, she became president and CEO.

Aptar Announces the Completion of the Acquisition of a Majority Stake in Voluntis

Retrieved on: 
Thursday, September 2, 2021
Packaging, Pharmaceutical, Health, Manufacturing, Patient, Acquisition, Securities Act of 1933, Tender offer, U.S. Securities and Exchange Commission, AMF, Analysis, Form, Science, Market, Security (finance), Result, Engineering, Forward-looking statement, Tender, ATR, Securities Exchange Act of 1934, Board, Institutional review board, Beauty, Food, Compliance, AptarGroup, Financial condition report, Health, NYSE, Fine chemical, Risk management

The stake acquisition represents approximately 64.6% of the share capital of Voluntis (on a non-diluted basis), at a price of 8.70 per share.

Key Points: 
  • The stake acquisition represents approximately 64.6% of the share capital of Voluntis (on a non-diluted basis), at a price of 8.70 per share.
  • If the regulatory conditions are met upon completion of the Tender Offer, Aptar intends to implement a squeeze-out on the remaining outstanding shares of Voluntis.
  • This press release contains forward-looking statements, including regarding the potential acquisition of Voluntis and the anticipated effects of the acquisition.
  • Aptar undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable Drug Delivery

Retrieved on: 
Wednesday, July 28, 2021
Pharmaceutical, Medical Supplies, Health, Medical devices, Chemicals, Plastics, Supply chain management, Manufacturing, Retail, AptarGroup

This transaction will meet our disciplined investment approach and Hengyus capabilities are complementary to our growing portfolio of injectable solutions.

Key Points: 
  • This transaction will meet our disciplined investment approach and Hengyus capabilities are complementary to our growing portfolio of injectable solutions.
  • Wang Yingye, Co-Founder of Hengyu, stated, Aptar is a world leader in drug delivery solutions.
  • Hengyu shares the same vision as Aptar - to be a drug delivery expert, providing unique, high quality products to the healthcare industry.
  • Located in Weihai, a coastal city in Shandong Province of eastern China, Hengyu designs and manufacturers elastomeric and plastic components used in delivering injectable drugs.

Aptar Announces the Signature of a Share Purchase Agreement Regarding the Acquisition of a Majority Stake in Voluntis at a Price of €8.70 Per Share

Retrieved on: 
Friday, July 23, 2021
Packaging, Manufacturing, Corporate finance, Corporate law, Squeeze-out, Stock market, AptarGroup, Government procurement in the United States, Tender offer

After and subject to completion of this acquisition, Aptar will launch a mandatory cash tender offer to acquire Voluntis remaining shares for the same price of 8.70 per share (the Tender Offer).

Key Points: 
  • After and subject to completion of this acquisition, Aptar will launch a mandatory cash tender offer to acquire Voluntis remaining shares for the same price of 8.70 per share (the Tender Offer).
  • If the regulatory conditions are met upon completion of the Tender Offer, Aptar intends to implement a squeeze-out on the remaining outstanding shares of Voluntis.
  • This press release contains forward-looking statements, including regarding the potential acquisition of Voluntis and the anticipated effects of the acquisition.
  • Aptar undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Aptar Declares Quarterly Dividend

Retrieved on: 
Thursday, July 22, 2021
Packaging, Manufacturing, AptarGroup

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share.
  • As previously announced, Aptar will hold a conference call on Friday, July 30, 2021 at 8:00 a.m. Central Time to discuss the Companys second quarter results for 2021.
  • Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

Aptar Announces Strategic Collaboration with YAT, a Chinese Online Skincare Company, to Develop Range of Products and Services for the Skincare Market

Retrieved on: 
Wednesday, July 7, 2021
Luxury, Women, Department Stores, Packaging, Chemicals, Plastics, Specialty, Manufacturing, Consumer, Cosmetics, Retail, AptarGroup, Aptar, YAT, APTAR, YAT

Stephan Tanda, Aptar President and CEO, stated, We are pleased to collaborate with YAT to bring new skincare solutions to market.

Key Points: 
  • Stephan Tanda, Aptar President and CEO, stated, We are pleased to collaborate with YAT to bring new skincare solutions to market.
  • Having Aptars resources will bolster our products and services, meeting the increasingly high demands of the market which increasingly also has a sustainability angle.
  • In addition to the partnership, Aptar has made a strategic equity investment in YAT during their latest round of funding.
  • We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.